Bio & Pharma
GCCL develops Korea's first automatic clinical trial data sharing system
Automatic data-sharing system will prevent human errors and improve expertise in clinical trial sample analysis
By Jan 10, 2023 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


KT&G eyes overseas M&A after rejecting activist fund's offer


StockX in merger talks with Naver’s online reseller Kream


Mirae Asset to be named Korea Post’s core real estate fund operator



Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Korea's first clinical trial automatic data-sharing system with CRScube, a company specializing in clinical software solutions.
GCCL is a Good Clinical Laboratory Practice (GCLP)-certified agency of the Ministry of Food and Drug Safety of South Korea and is a clinical trial sample analysis company that provides services for all phases of clinical trials from phase 1 to 4.
Through this joint development, GCCL will be able to provide customers with fast and accurate clinical analysis results by linking its clinical trial project management system G-HUB with CRSCube's electronic data capture solution cubeCDMS.
G-HUB allows a real-time verification of clinical trial samples from transportation to analysis and reporting results, while cubeCDMS is a software program that collects and integrates data on the entire cycle of clinical trials.
"We hope that the automated data sharing system will replace existing manual tasks to prevent human errors and improve expertise in clinical trial sample analysis," an official of GCCL said.
Write to Ji-Hyun Lee at bluesky@hankyung.com
More to Read
-
Green Cross' two Kosdaq-listed cell therapy arms to merge
Jul 18, 2021 (Gmt+09:00)
2 Min read -
COVID-19Green Cross in talks with Russia to produce COVID-19 vaccine
Mar 18, 2021 (Gmt+09:00)
3 Min read
Comment 0
LOG IN